ADAM ROSENBERG: Open Payments
NPI 1922504810 · HICKSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,135 in 163 payments from 24 companies in 2025. Trend: 2023 $3,178 · 2024 $3,782 · 2025 $4,135
Food & beverage: $4,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $876 |
| Axsome Therapeutics, Inc. | 12 | $497 |
| Janssen Biotech, Inc. | 18 | $462 |
| PFIZER INC. | 15 | $374 |
| Lilly USA, LLC | 15 | $321 |
| UCB, Inc. | 12 | $303 |
| Novartis Pharmaceuticals Corporation | 10 | $249 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $194 |
| Boston Scientific Corporation | 3 | $130 |
| Azurity Pharmaceuticals, Inc. | 6 | $125 |
Products named: Symbravo, TREMFYA, UBRELVY, Bimzelx, NURTEC ODT, COSENTYX, TALTZ, RINVOQ.
Industry payments across NY — which companies pay providers there.
